Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 21555532)

1.

Murine guanylate cyclase C regulates colonic injury and inflammation.

Steinbrecher KA, Harmel-Laws E, Garin-Laflam MP, Mann EA, Bezerra LD, Hogan SP, Cohen MB.

J Immunol. 2011 Jun 15;186(12):7205-14. doi: 10.4049/jimmunol.1002469. Epub 2011 May 9.

2.

Guanylate cyclase C deficiency causes severe inflammation in a murine model of spontaneous colitis.

Harmel-Laws E, Mann EA, Cohen MB, Steinbrecher KA.

PLoS One. 2013 Nov 11;8(11):e79180. doi: 10.1371/journal.pone.0079180. eCollection 2013.

3.

Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.

Carrithers SL, Ott CE, Hill MJ, Johnson BR, Cai W, Chang JJ, Shah RG, Sun C, Mann EA, Fonteles MC, Forte LR, Jackson BA, Giannella RA, Greenberg RN.

Kidney Int. 2004 Jan;65(1):40-53.

PMID:
14675035
4.

Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis.

Garin-Laflam MP, Steinbrecher KA, Rudolph JA, Mao J, Cohen MB.

Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G740-9. doi: 10.1152/ajpgi.90268.2008. Epub 2009 Feb 12.

5.

Resistin-like molecule beta regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice.

Krimi RB, Kotelevets L, Dubuquoy L, Plaisancié P, Walker F, Lehy T, Desreumaux P, Van Seuningen I, Chastre E, Forgue-Lafitte ME, Marie JC.

Inflamm Bowel Dis. 2008 Jul;14(7):931-41. doi: 10.1002/ibd.20420.

PMID:
18300276
6.

Guanylin peptides: cyclic GMP signaling mechanisms.

Forte LR, Freeman RH, Krause WJ, London RM.

Braz J Med Biol Res. 1999 Nov;32(11):1329-36.

7.

Goblet cell-derived resistin-like molecule beta augments CD4+ T cell production of IFN-gamma and infection-induced intestinal inflammation.

Nair MG, Guild KJ, Du Y, Zaph C, Yancopoulos GD, Valenzuela DM, Murphy A, Stevens S, Karow M, Artis D.

J Immunol. 2008 Oct 1;181(7):4709-15.

8.

Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation.

Silos-Santiago I, Hannig G, Eutamene H, Ustinova EE, Bernier SG, Ge P, Graul C, Jacobson S, Jin H, Liong E, Kessler MM, Reza T, Rivers S, Shea C, Tchernychev B, Bryant AP, Kurtz CB, Bueno L, Pezzone MA, Currie MG.

Pain. 2013 Sep;154(9):1820-30. doi: 10.1016/j.pain.2013.05.044. Epub 2013 Jun 5.

9.

Heat-stable enterotoxin of Escherichia coli (STa) can stimulate duodenal HCO3(-) secretion via a novel GC-C- and CFTR-independent pathway.

Sellers ZM, Mann E, Smith A, Ko KH, Giannella R, Cohen MB, Barrett KE, Dong H.

FASEB J. 2008 May;22(5):1306-16. Epub 2007 Dec 20.

10.

Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis.

McVay LD, Keilbaugh SA, Wong TM, Kierstein S, Shin ME, Lehrke M, Lefterova MI, Shifflett DE, Barnes SL, Cominelli F, Cohn SM, Hecht G, Lazar MA, Haczku A, Wu GD.

J Clin Invest. 2006 Nov;116(11):2914-23. Epub 2006 Oct 5.

11.

The guanylate cyclase-C signaling pathway is down-regulated in inflammatory bowel disease.

Brenna Ø, Bruland T, Furnes MW, Granlund AV, Drozdov I, Emgård J, Brønstad G, Kidd M, Sandvik AK, Gustafsson BI.

Scand J Gastroenterol. 2015 May 15:1-12. [Epub ahead of print]

PMID:
25979109
12.

Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.

Castro J, Harrington AM, Hughes PA, Martin CM, Ge P, Shea CM, Jin H, Jacobson S, Hannig G, Mann E, Cohen MB, MacDougall JE, Lavins BJ, Kurtz CB, Silos-Santiago I, Johnston JM, Currie MG, Blackshaw LA, Brierley SM.

Gastroenterology. 2013 Dec;145(6):1334-46.e1-11. doi: 10.1053/j.gastro.2013.08.017. Epub 2013 Aug 16.

13.

Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice.

Naito Y, Takagi T, Handa O, Ishikawa T, Nakagawa S, Yamaguchi T, Yoshida N, Minami M, Kita M, Imanishi J, Yoshikawa T.

J Gastroenterol Hepatol. 2003 May;18(5):560-9.

PMID:
12702049
14.

Cellular effects of guanylin and uroguanylin.

Sindić A, Schlatter E.

J Am Soc Nephrol. 2006 Mar;17(3):607-16. Epub 2005 Dec 28. Review.

15.

Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity.

Hamra FK, Eber SL, Chin DT, Currie MG, Forte LR.

Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2705-10.

16.

Renal effects of uroguanylin and guanylin in vivo.

Carrithers SL, Hill MJ, Johnson BR, O'Hara SM, Jackson BA, Ott CE, Lorenz J, Mann EA, Giannella RA, Forte LR, Greenberg RN.

Braz J Med Biol Res. 1999 Nov;32(11):1337-44.

17.

Lack of guanylate cyclase C results in increased mortality in mice following liver injury.

Mann EA, Shanmukhappa K, Cohen MB.

BMC Gastroenterol. 2010 Aug 2;10:86. doi: 10.1186/1471-230X-10-86.

18.

Guanylin peptides: renal actions mediated by cyclic GMP.

Forte LR, London RM, Freeman RH, Krause WJ.

Am J Physiol Renal Physiol. 2000 Feb;278(2):F180-91. Review.

19.

Mechanisms of actions of guanylin peptides in the kidney.

Sindić A, Schlatter E.

Pflugers Arch. 2005 Aug;450(5):283-91. Epub 2005 Jun 11. Review.

PMID:
15952032
20.

Increases in guanylin and uroguanylin in a mouse model of osmotic diarrhea are guanylate cyclase C-independent.

Steinbrecher KA, Mann EA, Giannella RA, Cohen MB.

Gastroenterology. 2001 Nov;121(5):1191-202.

PMID:
11677212
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk